Clinical trial
Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium
NCT00332995 · International Partnership for Microbicides, Inc., Industry · Completed
Key facts
| NCT number | NCT00332995 |
|---|---|
| Title | Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium |
| Official title | Double-blind, Randomized, Placebo Controlled Trial to Study Safety, Local and Systemic Availability of TMC120 From a Vaginal Ring. |
| Lead sponsor | International Partnership for Microbicides, Inc., Industry |
| Collaborators | Tibotec Pharmaceutical Limited Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | dapivirine (TMC120) vaginal ring |
| Enrollment | 13 |
| Start date | Jul 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Jun 2, 2006 |
| Last update posted | Sep 1, 2009 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: